🔥Telegram İfşa

Now thats showings real love for your Paul OfficialЕvеnt Kenneth Michael😆 OfficialЕvеnt OfficialЕvеnt Ree Rida 😍Robert

I DONT HAVE WL BUT I JOINED THE RAFFLE 😭 @Salvado18682232 132x2146.bnb(💙,🧡) CryptoRose🌊RIVER Eric666 @Lawrence30Ouma Cas xiang modeganqing.bnb (💙,🧡) Yujie Jeep ❤

Oh yeah man✔ Corbs Johnson @AgapiosKar princeps @TripleOGMatty @Prosper2486 Future phantom007🔑 @0xmartwinx

im mint 2 nft @scarsolana Maks @ClockTickXBT smonav π² 🍊,💊 (❖,❖) base.eth Grouchy Perseus SUN DISC Erevøs77 ⛋🧪⚛️ @JubzDiVillin @assetmantlelove 🌌 JustBluish

Hybrid imaging improves diagnostic accuracy and patient care. PET/CT and PET/MR.

Cutting edge instrumentation and novel chemistry is winning combination @ USC Norris Imaging Core - Dr Peter Conti says @ Binational Symp

Nanodiamond-based drug delivery holds promise for overcoming chemoresistance - Dr Ed Chow (Singapore) @ Binational Symposium #USCNorris

Dr Richard Roberts discusses engineered peptides as cancer "theranostics" Potential for diagnosis and therapy. #USCNorris @ Binational Symp

Exciting science at 1st Binational US-Singapore Cancer Symposium - insights from two continents on breast cancer prevention and treatment.

Had a blast today #AACR15 visiting the @BarnesFoundation Thanks to AlMamun33! Very proud member #GruberLab

Congratulations Julia Sturgeon, MS, USC Master of Science #GruberLab #USC Norris

Dr Tonya Dorff #USCNorris presents valuable recommendations re: care of patients with prostate cancer with bone mets at #ASCO15

Promising data for mismatch repair deficient colorectal cancer. Promising day for patients with Lynch Syndrome. #ASCO2015

Congratulations Dr Dung Le #ASCO2015 - very impressive study using pembrolizumab for MSI-H CRC. Waterfall plot is stunning.

Dr Anthony El-Khoueiry presents safety of Nivolumab in hepatocellular cancer. Well tolerated. Impressive responses. #USCNorris #ASCO15

Interim analysis of Nivolumab shows 19% objective response rate and even CR in hepatocellular ca. Dr. El-Khoueiry shows #ASCO15 #USCNorris

Dr Roy Herbst concludes "Biomarkers and science drive the day for cancer patients." #ASCO15

Dr Ryan Nipp shows financial assistance to patients for travel/lodging improves clin trial participation. Outstanding! #ASC015 #lazarex

Dr Allison Kurian presents important data about 2nd opinions for breast cancer patients #ASC015. CanSORT group answering key questions.

Dr. Kurian notes "Remarkably few patients received 2nd medical opinions." 10% new dx patients got 2nd opinions, 3% recd chemo from 2nd MD